ArticleAnnals of surgical oncology2020

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.

Hatem Soliman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.